724 related articles for article (PubMed ID: 17983378)
21. CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity.
Beeler A; Zaccaria L; Kawabata T; Gerber BO; Pichler WJ
Allergy; 2008 Feb; 63(2):181-8. PubMed ID: 18005225
[TBL] [Abstract][Full Text] [Related]
22. Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Tohyama M; Watanabe H; Murakami S; Shirakata Y; Sayama K; Iijima M; Hashimoto K
Br J Dermatol; 2012 Feb; 166(2):322-30. PubMed ID: 21936856
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.
Takehara A; Aoyama Y; Kurosawa M; Shirafuji Y; Umemura H; Kamiya K; Ushigome Y; Kano Y; Shiohara T; Iwatsuki K
Br J Dermatol; 2016 Nov; 175(5):944-952. PubMed ID: 27087170
[TBL] [Abstract][Full Text] [Related]
24. Clinical features and prognostic factors in severe cutaneous drug reactions.
Yang MS; Kang MG; Jung JW; Song WJ; Kang HR; Cho SH; Min KU
Int Arch Allergy Immunol; 2013; 162(4):346-54. PubMed ID: 24193402
[TBL] [Abstract][Full Text] [Related]
25. Clinical spectrum of drug rashes due to antiepileptics.
Sharma VK; Vatve M; Sawhney IM; Kumar B
J Assoc Physicians India; 1998 Jul; 46(7):595-7. PubMed ID: 12152838
[TBL] [Abstract][Full Text] [Related]
26. Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases.
Bellón T; Alvarez L; Mayorga C; Morel E; Torres MJ; Martín-Díaz MA; Díaz R; Radial A; Carballo M; Blanca M
Br J Dermatol; 2010 May; 162(5):1014-22. PubMed ID: 20030638
[TBL] [Abstract][Full Text] [Related]
27. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
Yang Y; Xu J; Li F; Zhu X
Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
[TBL] [Abstract][Full Text] [Related]
28. Nonpigmenting fixed drug eruption as a possible abortive variant of toxic epidermal necrolysis: immunohistochemical and serum cytokine analyses.
Mizukawa Y; Shiohara T
Clin Exp Dermatol; 2010 Jul; 35(5):493-7. PubMed ID: 19874369
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
Sotozono C; Ueta M; Koizumi N; Inatomi T; Shirakata Y; Ikezawa Z; Hashimoto K; Kinoshita S
Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
[TBL] [Abstract][Full Text] [Related]
30. [Cutaneous reactions to drugs].
Mulder WM; Meinardi MM; Bruynzeel DP
Ned Tijdschr Geneeskd; 2004 Feb; 148(9):415-20. PubMed ID: 15038200
[TBL] [Abstract][Full Text] [Related]
31. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis].
Yamane Y; Aihara M; Tatewaki S; Matsukura S; Kanbara T; Yamakawa Y; Ikezawa Z
Arerugi; 2009 May; 58(5):537-47. PubMed ID: 19487835
[TBL] [Abstract][Full Text] [Related]
32. Phenotype standardization for immune-mediated drug-induced skin injury.
Pirmohamed M; Friedmann PS; Molokhia M; Loke YK; Smith C; Phillips E; La Grenade L; Carleton B; Papaluca-Amati M; Demoly P; Shear NH
Clin Pharmacol Ther; 2011 Jun; 89(6):896-901. PubMed ID: 21562486
[TBL] [Abstract][Full Text] [Related]
33. Epidemiological study of severe cutaneous adverse drug reactions in a city district of China.
Li LF; Ma C
Clin Exp Dermatol; 2006 Sep; 31(5):642-7. PubMed ID: 16901302
[TBL] [Abstract][Full Text] [Related]
34. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis.
Ziemer M; Wiesend CL; Vetter R; Weiss J; Blaschke S; Norgauer J; Mockenhaupt M
Arch Dermatol; 2007 Jun; 143(6):711-6. PubMed ID: 17576936
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic allergies in children and adults: from clinical symptoms to skin testing diagnosis.
Romano A; Caubet JC
J Allergy Clin Immunol Pract; 2014; 2(1):3-12. PubMed ID: 24565763
[TBL] [Abstract][Full Text] [Related]
37. Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy.
Mockenhaupt M
J Dtsch Dermatol Ges; 2009 Feb; 7(2):142-60; quiz 161-2. PubMed ID: 19371237
[TBL] [Abstract][Full Text] [Related]
38. [Alarm signs in drug-induced skin reactions].
Schmied-Dufour C; Schmied E
Ther Umsch; 1993 Jan; 50(1):20-2. PubMed ID: 8378862
[TBL] [Abstract][Full Text] [Related]
39. Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Hung CC; Liu WC; Kuo MC; Lee CH; Hwang SJ; Chen HC
Am J Nephrol; 2009; 29(6):633-8. PubMed ID: 19155617
[TBL] [Abstract][Full Text] [Related]
40. The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.
Kano Y; Shiohara T
Immunol Allergy Clin North Am; 2009 Aug; 29(3):481-501. PubMed ID: 19563993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
